Telesis Bio Raises $21 Million from Novalis LifeSciences and Northpond Ventures

Telesis Bio secures approximately $21 million in funding round to empower scientists and revolutionize DNA and mRNA synthesis.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here